Acute External Ventricular Drain Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Acute external ventricular drains are catheter-based neurosurgical devices deployed in hospital intensive care units and neurosurgery departments to relieve elevated intracranial pressure and enable continuous intracranial pressure monitoring. The global market was valued at approximately USD 0.359 billion in 2026 and is projected to grow at a CAGR of around 8.9% through 2031. Growth is underpinned by rising prevalence of traumatic brain injury, hemorrhagic stroke, and other acute hydrocephalus indications requiring urgent CSF diversion.

The principal growth drivers include the rising global incidence of traumatic brain injuries from road accidents and falls, an increasing burden of hemorrhagic stroke associated with aging populations, and broader adoption of guideline-directed intracranial pressure monitoring in neurocritical care. Expansion of dedicated stroke centers and neurosurgical ICUs, particularly in Asia-Pacific and Latin America, is increasing procedural volumes. Additionally, technological improvements such as antimicrobial-coated catheters, tunneling techniques that reduce infection risk, and integration with digital ICP monitoring platforms are supporting premium pricing and replacement cycles.

The market is segmented by indication (traumatic brain injury, subarachnoid hemorrhage, intracerebral hemorrhage, and other acute hydrocephalus conditions), by patient type (adult and pediatric), and by end-user (primarily hospitals, with specialty neurosurgery and trauma centers representing the highest-volume users). North America currently accounts for the largest revenue share due to high procedural volumes, established reimbursement, and concentration of level I trauma centers, while Asia-Pacific is the fastest-growing region driven by healthcare investment in China, India, and Southeast Asia. Europe represents a mature, stable market with steady replacement-driven demand.